1
|
Mohan V, Misra A, Bloomgarden Z. Type 2 diabetes in the young in South Asia: Clinical heterogeneity and need for aggressive public health measures. J Diabetes 2021; 13:610-612. [PMID: 33963811 DOI: 10.1111/1753-0407.13201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Affiliation(s)
- Viswanathan Mohan
- Madras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialities Centre, Chennai, India
| | - Anoop Misra
- Fortis CDOC Centre for Diabetes and Allied Sciences, National Diabetes and Cholesterol Foundation and Diabetes Foundation (India), New Delhi, India
| | - Zachary Bloomgarden
- Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| |
Collapse
|
2
|
Hari Kumar KVS. Novel Approaches in the Management of Type 2 Diabetes and Associated Vascular Complications. ANNALS OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES (INDIA) 2021. [DOI: 10.1055/s-0041-1731146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
Abstract
AbstractDiabetes mellitus (DM) is growing in pandemic proportion and affects the affluent and developing nations equally. India has the dubious distinction of being known as the diabetes capital of the world. Epidemiological studies have shown that DM is under diagnosed and inadequately treated in our country. Insulin resistance and β-cell dysfunction are the two key pathophysiological determinants of the DM. The disease has metamorphosed during the last couple of decades with a significant change in the clinical presentation. Simultaneously, the therapeutic options for the management of DM have also increased in the last decade. This article highlights the research conducted by us over the last decade in the areas of pathogenesis, management, and complications of DM.
Collapse
|
3
|
Ma X, Fang C, Yan J, Zhao Q, Tu Y. A label-free electrochemiluminescent immunosensor for glutamate decarboxylase antibody detection on AuNPs supporting interface. Talanta 2018; 186:206-214. [DOI: 10.1016/j.talanta.2018.04.052] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2018] [Revised: 04/13/2018] [Accepted: 04/16/2018] [Indexed: 10/17/2022]
|